Methotrexate (MTX) was an effective treatment of resistant juvenile rheumatoid arthritis (JRA) in a double blind, placebo controlled study.1 Its advantagesas a first choice for children with refractory JRA.6 7 We considered the duration of MTX therapy required for the achievement of partial and...